A Multicenter, Randomized, Open Label Phase II Study of KLH-2109 in Patients With Endometriosis(3)
Phase of Trial: Phase II
Latest Information Update: 14 Jul 2014
At a glance
- Drugs KLH 2109 (Primary)
- Indications Endometriosis
- Focus Therapeutic Use
- Sponsors Kissei Pharmaceutical
- 29 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 29 Jun 2012 New trial record